For people living with ulcerative colitis (UC), cycles of remission and relapse can disrupt daily life and complicate long-term management. Sphingosine-1-phosphate receptor modulators (S1Prms) are a new class of targeted oral therapies with the potential to reduce colonic inflammation and improve outcomes. Initiating them follows a clear, well-defined pathway: a focused set of baseline assessments supports safe, confident use and helps teams match the right patients to therapy. With practical, evidence-based education, clinicians and multidisciplinary care teams can bring S1Prms into routine practice with confidence. This CME Outfitters recorded webcast makes that pathway clear and approachable, with expert faculty modeling how to fold baseline assessment into real-world workflows. It brings together perspectives from across the care team, including academic experts, community providers, gastroenterology, cardiology, and nurse practitioners, so the guidance translates for all providers.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Pricing
CME included with membership
| Integrative Psychiatry Certificate Program | $3,350 |
Collected from the provider’s public pages · source
Specialties served/covered
- Addiction Medicine
- Addiction Psychiatry
- Adolescent Medicine
- Allergy & Clinical Immunology
- Cardiovascular Disease
- Communication & Shared Decision-Making
- Critical Care Medicine
- Diagnostic Radiology
- Emergency Medicine
- Endocrinology, Diabetes & Metabolism
- Family Medicine
- Gastroenterology
- General & Adult Psychiatry
- General Internal Medicine
- General Operative Anesthesia
- General Otolaryngology
- General Pediatrics
- General Surgery
- Gynecologic Oncology
- Hematology
- Hospice & Palliative Medicine
- Medical Oncology
- Mood & Anxiety Disorders
- Neonatal-Perinatal Medicine
- Neurology
- Neuromuscular Medicine
- Neuroradiology
- Nuclear Medicine
- Obstetrics & Gynecology
- Ophthalmology
- Orthopaedic Surgery
- Pain Medicine
- Physical Medicine & Rehabilitation
- Practice Management & Ethics
- Primary Care Sports Medicine
- Pulmonary Disease
- Radiation Oncology
- Regional Anesthesia & Acute Pain
- Rheumatology
- Sleep Medicine
- Surgical Oncology
- Thoracic Surgery
- Urological Oncology
- Anesthesiology
- Cardio-Vascular
- Cross-Specialty
- Emergency & Critical Care
- ENT & Head Neck
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Orthopedics
- Pain & Palliative
- Pediatrics
- Primary care
- Psychiatry
- Radiology
- Rehabilitation
- Sports & Exercise Medicine
- Surgery
- Urology
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- On-demand / recorded video
- Credit · Up to 1 credit
- MOC · Up to 1 point
- Commercial Support
-
ReleasedAug 4, 2026
-
Last day to claim creditFeb 5, 2027 4 months left
-
American Gastroenterological Association (AGA) Institute Differential Efficacy of Advanced Therapies in Inducing Remission in Ulcerative Colitis Based on Prior Exposure to TNF Antagonists
-
Medscape, LLC Targeting New Pathways in the Treatment of Ulcerative Colitis
-
Answers in CME Inc. (AiCME) From Initial to Maintenance Pharmacotherapy for EoE: Stepping Up Multidisciplinary Long-Term Care
-
CME Outfitters, LLC Beyond the Bowel: Addressing Obesity as a Modifiable Driver of IBD Outcomes
-
CME Outfitters, LLC A CaseWise Initiative Mission Possible: Matching Treatment Goals of Patients and Providers in IBD in Clinical Practice
-
CME Outfitters, LLC Livestream: Beyond the Bowel: Addressing Obesity as a Modifiable Driver of IBD Outcomes
